Clinical Trial Update: Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing ipatasertib plus abiraterone plus prednisone/prednisolone vs placebo plus abiraterone plus prednisone/prednisolone in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• PREDNISONE (Prednisone)
• Prednisolone (Prednisolone)
• ipatasertib (ipatasertib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-04-10